According to FutureWise analysis, the market for Collagenase Clostridium Histolyticum in 2023 is US$0.78 billion, and is expected to reach US$1.02 billion by 2031 at a CAGR of 3.50%. The global market for Collagenase Clostridium Histolyticum (CCH) was valued at an impressive USD 1.5 billion in 2024 and is anticipated to nearly double, reaching around USD 3.2 billion by 2033. This substantial...

According to FutureWise analysis, the market for collagen filler in 2023 is US$0.48 billion, and is expected to reach US$0.86 billion by 2031 at a CAGR of 7.4%. The global collagen filler market is currently estimated to be valued at approximately USD 560.6 million in 2025, with projections indicating a substantial increase to USD 924.0 million by 2032. This remarkable growth is expected to...

According to FutureWise analysis, the market for Collagen Dressings in 2023 is US$1.11 billion, and is expected to reach US$1.7 billion by 2031 at a CAGR of 5.40%. The global collagen dressings market is anticipated to experience significant growth, increasing from USD 2.36 billion in 2025 to USD 4.25 billion by 2034. This expansion represents a compound annual growth rate (CAGR) of...

According to FutureWise analysis, the market for cold compression therapy in 2023 is US$3.91 billion, and is expected to reach US$6.1 billion by 2031 at a CAGR of 5.70%. Cold compression therapy is a treatment designed for acute injuries that combines cold therapy with compression therapy to provide optimal relief from pain and swelling. This method integrates static compression and...

According to FutureWise analysis, the market for coagulation testing in 2023 is US$3.85 billion, and is expected to reach US$9.14 billion by 2031 at a CAGR of 11.4%. The transformation of fibrinogen, a fluid protein found in plasma, into fibrin, a solid gel, dramatically alters the physical properties of our blood. To understand how well our blood can clot and how quickly it does so, we turn...

The global market for coagulation factors is experiencing significant growth, driven by the increasing prevalence of bleeding disorders, including hemophilia A and B, as well as von Willebrand disease. This surge is accompanied by a rising adoption of both recombinant and plasma-derived therapies. Breakthroughs in long-acting treatments and gene-based therapies are revolutionizing patient care,...

The global coagulation disorders market is experiencing robust growth, primarily fueled by the rising prevalence of bleeding disorders such as hemophilia and von Willebrand disease. Awareness of these conditions is expanding, complemented by significant improvements in diagnostic technologies that enhance detection capabilities. Recent advancements in treatment modalities, including innovative...

According to FutureWise analysis, the market for CO2 incubators in 2023 is US$0.72 billion, and is expected to reach US$1.07 billion by 2031 at a CAGR of 5.20%. The global CO₂ incubator market was valued at approximately USD 1.80 billion in 2024 and is projected to experience significant growth, reaching around USD 2.89 billion by 2034. This growth trajectory represents a compound annual...

According to FutureWise analysis, the market for closed system transfer devices in 2023 is US$1.16 billion, and is expected to reach US$4.8 billion by 2031 at a CAGR of 19.4%. The global market for Closed System Transfer Devices (CSTDs) is currently experiencing robust expansion, with sales projected to reach approximately USD 1.03 billion in 2024. This figure is expected to grow...

According to FutureWise analysis, the market for Clinical Trial Imaging in 2023 is US$1.3 billion, and is expected to reach US$2.36 billion by 2031 at a CAGR of 7.70%. In 2024, the global clinical trial imaging market was valued at approximately USD 1.23 billion and is poised for significant growth, projected to reach around USD 1.91–2.07 billion by the end of the decade. This growth...